ClinicalTrials.gg
Not yet recruitingNCT07453160CHXvsNaOCl-PaiUpdated Mar 5, 2026

Comparing Two Root Canal Cleaning Solutions (Chlorhexidine vs. Sodium Hypochlorite) for Pain After Treatment

An interventional study of Chlorhexidine gluconate 2% and Sodium hypochlorite 5.25% in Postoperative Pain, sponsored by College of Physicians and Surgeons Pakistan. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-03-05.

Sponsored by College of Physicians and Surgeons Pakistan · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Brief Summary (A short description for the lay public)

This study aims to find out if the type of cleaning solution used during a root canal affects the pain a patient feels the next day. A root canal procedure involves cleaning the inside of the tooth. Two common cleaning solutions are chlorhexidine (CHX) and sodium hypochlorite (NaOCl, also known as bleach). While both are effective, it is not clear if one causes more discomfort than the other.

In this research, half of the participants will have their root canal cleaned with CHX, and the other half with NaOCl. We will then ask all participants to rate their pain 24 hours after the procedure using a simple pain scale. Our goal is to see if there is a difference in pain levels between the two groups. The results will help dentists choose the best solution to make their patients more comfortable after treatment

Read the detailed description

Detailed Description (Extended technical description of the protocol)

This study is designed as a randomized controlled trial to compare the intensity of postoperative pain 24 hours after non-surgical root canal treatment using two different irrigating solutions: 2% chlorhexidine (CHX) and 5.25% sodium hypochlorite (NaOCl). The central hypothesis is that the type of irrigant influences early postoperative pain, but that this effect may be modified by patient-specific factors such as gender and age.

Methodology:

Following ethical approval and informed consent, 90 adult patients indicated for non-surgical root canal treatment will be enrolled using a non-probability consecutive sampling technique. Participants will be randomly allocated to one of two parallel groups (n=45 per group): Group A (2% CHX) and Group B (5.25% NaOCl). The sample size was calculated a priori using the pwr package in R, assuming a 95% confidence level, 80% power, and a moderate effect size based on previous studies.

A standardized endodontic protocol will be followed for all participants to ensure consistency and minimize bias:

Procedure: After administering local anesthesia (2% lignocaine with 1:80,000 adrenaline), the operative field will be isolated with a rubber dam. Standard endodontic access will be prepared, and the working length will be determined using digital radiography.

Instrumentation and Irrigation: Chemo-mechanical preparation will be performed. Irrigation will be carried out using 2 ml of the assigned solution after each instrument. The solution will be delivered using a 27-gauge side-vented needle (Max-i-Probe) kept 1-2 mm short of the working length and maintained in motion to prevent apical extrusion. The flow rate will be controlled at 2-4 ml/min.

Obturation and Follow-up: Canals will be dried with sterile paper points and obturated with gutta-percha and sealer. Participants will be provided with a questionnaire to record their pain after 24 hours using a Visual Analog Scale (VAS). Pain scores will be categorized as no pain (0), mild (1-30), moderate (31-50), or severe (51-100).

Data Analysis:

Data will be analyzed using R software (version 4.3.3). Descriptive statistics (mean, SD, frequencies) will be calculated. Comparative analyses between the two groups will be conducted using the Student's t-test for mean pain scores and the Chi-square test for categorical pain types. Statistical significance will be set at p \< 0.05. A key aspect of the analysis plan includes pre-planned subgroup analyses stratified by gender and age to explore their interaction with the irrigant used.

02

Conditions studied

  • Postoperative Pain

Browse trials for

Keywords

  • Postoperative pain
  • Root canal treatment
03

In context

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

This study's planned enrollment of 90 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

College of Physicians and Surgeons Pakistan is the lead sponsor of 15 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

Adults aged 18-65 years

  • Any gender
  • Requiring non-surgical root canal treatment
  • Willing to provide written
  • Able to report postoperative pain using a validated pain assessment scale -

Exclusion Criteria:Known or allergy to chlorhexidine or sodium hypochlorite

  • Systemic conditions affecting pain perception (e.g., diabetes with neuropathy, fibromyalgia)
  • Medications affecting pain perception (e.g., chronic analgesics, , antidepressants)
  • Preoperative dental pain in the tooth scheduled for treatment
  • Pregnancy or lactation
  • Teeth with resorbed roots
  • Mobile teeth (pathological mobility)
  • Open apices
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    2% Chlorhexidine Group

    Root canal irrigation with 2% chlorhexidine gluconate solution. 2 mL after each instrument, 27-gauge side-vented needle, 1-2 mm short of working length, passive flow 2-4 mL/min.

    Procedure: Chlorhexidine gluconate 2% · Drug: Sodium hypochlorite 5.25%

  • Active comparator
    5.25% Sodium Hypochlorite Group

    Root canal irrigation with 5.25% sodium hypochlorite solution. 2 mL after each instrument, 27-gauge side-vented needle, 1-2 mm short of working length, passive flow 2-4 mL/min.

    Procedure: Chlorhexidine gluconate 2% · Drug: Sodium hypochlorite 5.25%

Interventions

  • ProcedureChlorhexidine gluconate 2%

    2% chlorhexidine gluconate solution used as root canal irrigant. Clear, colorless, odorless liquid. Broad-spectrum antimicrobial with substantivity (binds to dental tissues, prolonged effect up to 72 hours). Does not dissolve organic tissue. Lower cytotoxicity than NaOCl. Applied at 2 mL per instrument, delivered via 27-gauge side-vented Max-i-Probe needle placed 1-2 mm short of working length, passive flow at 2-4 mL/min, continuous needle motion. Room temperature. Final irrigation with same solution

  • DrugSodium HypochloriteStudies of Sodium HypochloriteSodium Hypochlorite pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    5.25% sodium hypochlorite solution used as root canal irrigant. Pale yellow liquid with characteristic chlorine odor. Broad-spectrum antimicrobial with rapid bactericidal action. Dissolves organic pulp tissue and necrotic debris. Cytotoxic to periapical tissues if extruded. No substantivity. Applied at 2 mL per instrument, delivered via 27-gauge side-vented Max-i-Probe needle placed 1-2 mm short of working length, passive flow at 2-4 mL/min, continuous needle motion. Room temperature. Final irrigation with same solution.

06

What researchers measure

Primary outcomes

  1. Postoperative pain intensity at 24 hours

    Pain intensity measured using a 4-point Visual Analog Scale (VAS): 0 = no pain, 1 = mild pain, 2 = moderate pain (required analgesics with relief), 3 = severe pain (analgesics no relief). Patient-reported 24 hours post-treatment.

    Time frame: 24 hours after root canal treatment completion

  2. Postoperative pain intensity at 24 hours

    Pain intensity measured using a 4-point Visual Analog Scale (VAS): 0 = no pain, 1 = mild pain, 2 = moderate pain (required analgesics with relief), 3 = severe pain (analgesics no relief). Patient-reported 24 hours post-treatmen

    Time frame: 24 hours after root canal treatment completion

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2026; primary completion for Jun 2026, 4 months later.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 4 months is below that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 12, 2026
First posted
Mar 5, 2026
StartEst.
Feb 15, 2026
Primary completionEst.
Jun 15, 2026
CompletionEst.
Jun 15, 2026
Last update
Mar 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07453160
Lead sponsor
College of Physicians and Surgeons Pakistan
Responsible party
Faiz ur rahman (Postgraduate Resident, Department of Operative Dentistry, College of Physicians and Surgeons Pakistan) — Principal investigator
First posted
Mar 5, 2026
Start date
Feb 15, 2026 (estimated)
Primary completion
Jun 15, 2026 (estimated)
Completion
Jun 15, 2026 (estimated)
Last update
Mar 5, 2026

Study contacts

Faiz Rahman, BDS
Contact
faizr3702@gmail.com
+923451505838

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Sodium Hypochlorite

Start the discussion